Skip to main content
PLOS One logoLink to PLOS One
. 2025 Jan 15;20(1):e0315922. doi: 10.1371/journal.pone.0315922

3D fluorescence staining and confocal imaging of low amount of intestinal organoids (enteroids): Protocol accessible to all

Ami Gloria Toulehohoun 1,*,#, Caroline Bouzin 2,#, Aurélie Daumerie 2, Luca Maccioni 3, Peter Stärkel 1,4
Editor: Ayman A Swelum5
PMCID: PMC11734922  PMID: 39813259

Abstract

The emerging field of 3D organ modeling encounters several imaging issues in particular related to antigen retrieval and sample loss during staining processes. Due to their compact shape, several antibodies fail to penetrate intact organoids or spheroids. Histology of organoids can be approached by paraffin inclusion and sectioning at 5 μm as performed for biopsies. However, to fully understand organoid behavior, including cellular organization, extracellular matrix structure, and their response to treatments, 3D imaging is essential. Here we propose an easy workflow allowing (1) immunostaining with a HIER step, (2) preservation of the intact shape of the organoids, (3) sample immobilization in a focal plane reachable for high resolution/short working distance lenses, and (4) minimizing the risk of loss of precious material.

Introduction

Organoids are 3D in vitro models, mimicking the native patient organ (healthy or pathologic) in terms of structural and functional aspects. They offer unparalleled potential for disease modelling and large-scale therapeutic screening [1]. Compared to animal models, organoids derived from patients’ cells translate into greater similarity in physiological and disease processes and offer a more ethically responsible approach.

Following proper characterization and in vitro expansion, these "mini-tissues" can be established as biobanks, serving as valuable research resources for biomarker identification and novel therapeutic target development. Furthermore, organoid models hold particular promise for studying rare pathologies, where limited access to biological material delays research progress. Their versatility extends to diverse areas, including tumor biology, inflammatory diseases, regenerative medicine, and more. Importantly, unlike formalin-fixed paraffin-embedded tissues, these "living biobanks" provide a source of fresh material suitable for a wide range of analyses, including histological, protein expression, genomic, and metabolomic studies.

Histology of organoids can be approached by paraffin inclusion and sectioning at 5 μm as performed for biopsies [2]. However, to fully understand organoid behavior, including cellular organization, extracellular matrix structure, and their response to treatments, 3D imaging is essential. Different imaging technologies allow for 3D imaging of these small (50–300 μm diameter) structures, like light sheet microscopy and confocal microscopy. Light sheet microscopy offers high imaging speed and good spatial resolution [35] while confocal microscopy is the most widely accessible device. Although sample positioning is challenging on both devices, organoid inclusion in agarose sticks for light sheet microscopy leads to a massive sample loss. For this reason, we focused on confocal microscopy.

The emerging field of 3D organ modeling requires adequate sample preparation in order to generate faithful representations of the real 3D structure. Heat induced epitope retrieval (HIER) is routinely used for 2D Formalin-Fixed Paraffin-Embedded (FFPE) sections. However, this technique cannot be extrapolated to 3D staining. To the best of our knowledge, HIER is not well established for 3D staining due to the complexity of the samples management.

First, fixation with formaldehyde is known to create crosslinking by forming covalent bonds between proteins [6]. This network can also be an obstacle to antibodies penetration. On 2D sections, HIER (acidic or basic pH) is commonly performed to break this network and make antigens accessible to antibodies [7]. Of note, fixation of organoids with methanol does not require antigen retrieval, yet our prior staining showed that this method is inappropriate for detecting some epitopes and the image quality is lower when compared to fixation performed with formaldehyde. Second, due to their compact shape and thickness, several antibodies fail to penetrate intact organoids. This can be worked around using detergents in the staining protocol. Third, light scattering and/or absorption by biological tissues is an obstacle to in depth imaging. However, optical clearing compounds are now available to render tissues transparent and straighten the light path, improving the thickness of samples that can be imaged in their entirety. Finally, when dispersed in a Matrigel dome, organoids are sometimes out of reach when using lenses with a magnification higher than x10. On the opposite, mounting organoids on a slide with a coverslip at the end of the staining leads to the flattening of the organoids and prevents from imaging them in their native shape.

Here we propose an easy workflow allowing (1) immunostaining with a HIER step, (2) preservation of the intact shape of the enteroids, (3) sample immobilization in a focal plane reachable for high resolution/short working distance lenses, and (4) minimizing the risk of loss of precious material (Fig 1).

Fig 1. Workflow of enteroid formation, staining and imaging.

Fig 1

Crypts are isolated (b) from duodenum-derived biopsies (a) and cultured in a Matrigel dome (c). Whole enteroids are retrieved from Matrigel after growth (d) and transferred to Matrigel-coated 24 well plates (e). After attachment, enteroids are fixed and submitted to microwave antigen retrieval (f) followed by immunolabeling (g). After clearing, images are acquired by a confocal microscope (g).

Methods

The protocol described in this peer-reviewed article is published on protocols.io (https://dx.doi.org/10.17504/protocols.io.kqdg323m7v25/v1) and is included for printing purposes as S1 File.

Ethics and study population

The study protocol conforms to the ethical guidelines of the 1975 Declaration of Helsinki and was approved by the institution’s human research and ethical committee (Comité Ethique Hospitalo-facultaire, Cliniques Universitaires Saint Luc, N° B403201422657). Written informed consent was obtained from all patients and controls. Patients hospitalized for selective alcohol withdrawal in a dedicated alcohol withdrawal unit and controls undergoing out-patient upper gastro-intestinal endoscopy for dyspepsia or reflux symptoms were recruited between 1st November 2023 and 30th July 2024. Control patients were only retained for the study if they had a normal gastro-intestinal endoscopy and no histological changes on the biopsy samples.

Crypt isolation ○ timing 3h

All the following steps are performed at 4°C on ice

  • ■ Collect duodenum biopsies in sterile PBS (without Ca2+ or Mg2+)

  • ■ Wash 3x2 min under mild rotation in PBS + antibiotics and antimycotic 100X (Invitrogen, 15240062)

  • ■ Incubate for 1h in 2mM EDTA in a 15 ml conic tube under slow rotation

  • ■ This step aims to loosen the crypts from the intestinal mucosa.

  • ■ Allow biopsies to settle down (10 sec) and discard the supernatant

  • ■ Add 1 ml dissociation buffer (43.4 mM sucrose + 54.9 mM D-sorbitol in DPBS) and transfer into 2 ml cryotube

  • ■ This step allows trapping of ions involved in molecular enzymatic degradation of the crypts

  • ■ Shake vigorously by hand. Allow biopsies to settle down (30 seconds) and collect the supernatant containing crypts in a 15 ml conic tube. The remaining biopsies will sediment in the cryotube.

  • ■ Repeat the previous step twice or three times to ensure total recovery of crypts

  • ■ Add 5 ml of DMEM medium supplemented with 1% Penicillin/Streptomycin and 20% FBS

  • ■ Centrifuge at 400 g for 8 min at 4°C

  • ■ Discard the supernatant

  • ■ Wash once in 2 ml DMEM medium

  • ■ Filter through 70 μm cell strainer

  • ■ Centrifuge at 400 g for 7 min at 4°C

  • ■ Discard the supernatant

  • ■ Resuspend the pellet in 20–30 μl cold Corning® Matrigel® Growth Factor Reduced (GFR) Basement Membrane Matrix, Phenol Red-free (VWR, 734–1101) and plate 25–30 μl per well in flat bottom 96 well plate (96 well plates, Greiner (G) Bio-one, CELLSTAR ® cat N° 655180)

  • ■ Incubate at 37°C, 5% CO2 for 10 min to allow the Matrigel to polymerize

  • ■ Add 37°C heated IntestiCult OGM Human (STEMCELL technologies, #06010) containing 1% Penicillin/Streptomycin

Enteroid passaging and culture ○ timing 7-14d

  • ■ Remove medium from the Matrigel dome

  • ■ Add 200 μl/well of Corning® Cell Recovery Solution (Corning, #734–0107)

  • ■ Incubate on ice for 40 min

  • ■ Pull the enteroids into a 15 ml conic tube

  • ■ Centrifuge at 400 g for 7 min

  • ■ Discard the supernatant

  • ■ Wash once with 2 ml cold DMEM medium

  • ■ Centrifuge 400 g for 7 min at 4°C

  • ■ Discard the supernatant

  • ■ Add 2 ml Gibco™ TrypLE™ Express Enzyme (1X), phenol red (Thermofisher, #12605010) to the pellet

  • ■ Incubate for 25 min at 37°C

  • ■ Neutralize with 3 ml DMEM medium containing FBS (1/20)

  • ■ Pipette up and down 10 times to dissociate remaining enteroids clusters

  • ■ Centrifuge as previously and discard the supernatant

  • ■ Wash once with DMEM

  • ■ Resuspend the pellet in cold Matrigel and plate approximately 15000 single cells in 20–30 μl per well in a flat bottom 96 well plate (Greiner (G) Bio-one, CELLSTAR ® cat N° 655180).

  #TIPS All enteroids are not dissociated into single cells. Some cluster or 3–5 cells could remain

  • ■ Add heated IntestiCult OGM Human (STEMCELL technologies, #06010) containing 1% Penicillin/Streptomycin

  • ■ Change medium every 2 days until day 6

  • ■ Change medium every day from day 7

Enteroid preparation for imaging

Plate coating ○ timing 30 min

  • ■ Dilute Matrigel 50x with cold PBS

  • ■ Plate 200 μl/well of diluted Matrigel in a 24 well plate (Greiner (G) Bio-one, CELLSTAR ® cat N° 62210)
    • ▲ CRITICAL STEP A thin homogeneous coating of Matrigel is critical to allow enteroids attachment in a similar plane.
    • ▲ CRITICAL STEP If high resolution is needed, select plates with coverslip bottom
  • ■ Incubate at least 20–30 min at 37°C to allow the Matrigel to polymerize

Enteroids retrieving ○ timing 3h

  • ■ Remove IntestiCult OGM Human culture medium from the enteroids

  • ■ Add 200 μl/well of Corning® Cell Recovery Solution (CRC, 354253)

  • ■ Place the plate on ice

  • ■ Incubate for 40 min on ice

  • ■ Transfer the detached enteroids in a 15 ml conic tube

  • ■ Wash each well 2X with Cell Recovery Solution and add this to the 15 ml tube

  • ■ Centrifuge at 400 g for 7 min at 4°C

  • ■ Discard the supernatant

  • ■ Wash 1x with DMEM medium

  • ■ Centrifuge as previously and discard the medium

  • ■ Add 200 μl/well culture medium on each pellet (containing treatment if applicable)

# TIPS Calculate the adequate volume depending on the total number of wells

  • ■ Remove the 24 well coated plate from the incubator and remove the excess PBS with 200 μl tips

  • ■ Plate 200 μl/well of cell suspension

  • ■ Incubate 1.5-2h at 37°C to allow the enteroids to attach to the plate

Fixation ○ timing 1h

  • ■ Remove the excess of medium

  • ■ Wash 1x with heated PBS (37°C)

  • ■ Fix with cold 4% formaldehyde for 45 min at 4°C

  • ■ Wash 1x with cold PBS (4°C)

       # TIPS Samples can be stored in PBS at 4°C, before being processed

       ! CAUTION Manipulate the formaldehyde under the hood.

  • ■ Proceed directly to permeabilization if the antibody does not require an antigen retrieval step

Antigen retrieval, permeabilization, blocking ○ timing 1 day

  • ■ Remove PBS

  • ■ Prepare 250 ml of citrate buffer:

add 25mL of citrate buffer stock solution 10x concentrated (3.78g citric acid and 24.12g sodium citrate dihydrate in 100ml distilled water, pH adjusted at 5.6, volume adjusted at 1l, storage at 4°C) and 675μL of 20% Triton-X100 solution (diluted in distilled water) in 225mL distilled water

  • ■ Fill each well with citrate buffer (1x) at RT

  • ■ Boil the remaining buffer in microwave at 900 Watt and keep it aside

  • ■ Put the plate in the microwave

  • ■ Heat at 900W until boiling (approximately 30 sec)

  • ■ Replace the citrate buffer by hot citrate buffer

  • ■ Repeat three times by filling the well before each boiling

  • ■ Heat at 90 Watt for 15 min

  • ■ Boil 3 times at 900 Watt

  • ■ Let the plate cool down for 10-15min

  • ■ wash 1X with distilled water

  • ■ Permeabilize and Block with Organoid Washing Buffer (OWB) overnight (Dekkers et al., 2019)

  •   • OWB : 1l of PBS containing 1 ml of Triton X-100 and 2g of BSA

Antibody staining ○ timing 2 days

  • ■ Dilute primary antibody (Table 1) in OWB solution

  • ■ Incubate enteroids with 300 μl of primary antibody solution overnight at 4°C

  • ■ Wash 2x 5 min with 500 μl OWB

  • ■ Incubate with 300 μl of secondary antibody (Table 1) in OWB solution overnight at 4°C

  • ■ Wash twice with OWB as described previously

  • ■ Incubate with 300 μl of DAPI (SIGMA D9542, stock 1μg/ml diluted 1:1000) for at least 1h

  • ■ Wash twice with OWB

  • ■ Wash with distilled water

  • ■ Remove completely the water

Table 1. Antibodies.

Antibodies Abbreviation Dilution Concentration Species Supplier Catalogue n° RRID
Mucin2 MUC2 1:200 1 μg/ml Mouse Santa Cruz Sc-515032 AB_2815005
Lyzozyme LYZ 1:400 0.625 μg/ml Rabbit Abcam Ab223503
Olfactomedin 4 OLFM4 1:200 0.035 μg/ml Rabbit Cell Signaling 14369S AB_2798465
E-cadherin E-cad 1:100 665 μg/ml Mouse Dako M3612
Zonula Occludens-1 ZO-1 1:100 2.5 μg/ml Rabbit Invitrogen 617300
Alexa FluorTM 488 donkey anti-mouse Anti-Ms 1:1500 1.33 μg/ml Donkey Invitrogen A21202
Alexa FluorTM 594 donkey anti-rabbit Anti-Rb 1:1500 1.33 μg/ml Donkey Invitrogen A21207

List of antibodies with their corresponding concentration and dilution.

Clearing and imaging

  • ■ Add 3 drops/well of RapiClear 1.49 (Sunjin Lab #RC147001)
    • ▲ CRITICAL STEP Without clearing, only the external cell layers are detectable.
  • ■ Image after 2h or the next day (Figs 24)

Fig 2. Confocal images of enteroids on day 18.

Fig 2

Staining of tight junctions using Zona occludens 1 (ZO-1) in purple shows specific binding of the antibody to its epitope without antigen retrieval (A) but not with antigen retrieval (B). DAPI in blue stains the nucleus. AIV & BIV, optical section of indicated volume in AIII and BIII. Scale bar 50 μm.

Fig 4. Confocal imaging of enteroids submitted to antigen retrieval on day 14.

Fig 4

E-cad (membrane protein) in green, marker of epithelial cells. IV., optical sections of indicated volume in III. 3D representation IV. Scale bar 50 μm.

Results and discussion

Results

See Figs 24.

Discussion

In order to assess the cell components of intestinal enteroids, we performed immunostaining to detect MUC2, LYZ, OLFM4, and ZO-1 proteins, respectively expressed by goblet, paneth, stem and stem-like cells and tight junctions. Entire enteroids were removed from Matrigel domes and were plated on a diluted Matrigel layer to immobilize them on a single plate for further imaging. In this protocol, the pre-formed enteroids are not embedded in the Matrigel and hence are directly accessible to antibodies with an accessible working distance from the objectives. Then, they were submitted to fixation and immunostaining without any prior antigen retrieval. They were finally imaged in a clearing solution with a confocal microscope.

Using this protocol, enteroids were attached to the plate without forcing or destroying their morphology. Furthermore, after their attachment and fixation, they were tightly stuck to the plate and did not detach during the HIER nor during the washing steps. Consequently, the number of enteroids before and after the staining was approximately the same, thus avoiding excessive loss of material.

The cellular localization of a protein of interest is an important element to assess the specificity of an immunostaining. The results represented in Fig 2 showed satisfactory tight junction protein ZO-1 detection. However, OLFM4, MUC2 and LYZ staining showed unspecific binding (mainly in the nucleus) of their respective antibodies.

We hypothesized that the lack of specific staining was due to inaccessibility of the antigens. As an antigen retrieval process, we first tried the FLASH technique proposed in a recent publication [8]. Although this approach might be successful for labeling of some epitopes, it did not allow to detect MUC2, LYZ and OLFM4 proteins in intestinal enteroids. However, as illustrated in Fig 3, we obtained specific staining of Muc2, OLFM4, LYZ protein in the enteroids using our protocol of convenient sample preparation while avoiding sample loss and imaging at the same focal length range. Compared to a traditional Immunostaining workflow on 2D sections of spheroids, we could avoid some challenging steps including: 1) the difficulty of finding organoids when sectioning, 2) time consuming 3) the lack of determining the level of the organoid/spheroid sectioned, 4) the limitation to acquiring only one layer [9].

Fig 3. Confocal imaging of enteroids on day 14.

Fig 3

A. OLFM4 (Olfactomedin 4) in red (A, B), Muc2 (Mucin 2) in green (C, D), Lyz (Lyzozyme) in red (E, F). Unspecific binding of OLFM4, MUC2, and LYZ respectively in (A), (C) and (E) without any prior antigen unmasking. B, D and F, specific binding of OLFM4, Muc2 and Lyz to stem cell and undifferentiated cells, Goblet cells and Paneth cells respectively after antigen retrieval. BIV., DIV and FIV, 3D representations of figures BIII, DIII and FIII respectively. Scale bar 50 μm.

These results support the added value of our protocol and indicate the need of appropriate antigen retrieval for detecting some epitopes by whole mount immunostaining [1012].

Conclusion

The technique suggested in this protocol allows enteroids to attach to the plate while keeping their shape and structure. After fixation, the attached enteroids are not removed throughout the whole staining process including Antigen retrieval and washing steps. Moreover, imaging entire enteroids by acquiring the different Z-stack positions prevents losing information about each single enteroid.

The advantage/ease of this technique is the use of a single plate with different experimental conditions, and we could use as low as 10 enteroids for the staining process. Moreover, no centrifugation process is required, and the washing steps are straight forward.

Limitations

Fixation of the enteroids on a plate does not allow Light-sheet microscopy since the enteroids are strongly attached to the plate and cannot be removed after the staining. Moreover, Imaging resolution is limited to 10X microscope lenses, and 96 well-plates are not suitable for this technique. Additionally, this protocol has been used only for enteroids even though it could be applied to other types of organoids.

Reagents

Dissociation buffer

Prepare the dissociation buffer by mixing 43.4 mM Sucrose solution (7.43 g in 500 ml distilled water, MW 342.3) and 54.9 mM sorbitol solution (5 g in 500 ml milli Q).

EDTA 2mM pH 8

Prepare 0.5 M stock solution by adding 93.05 g of ETDA (MW 372.2) to 500 ml of distilled water. Adjust pH to 8. Dilute 250X the stock solution for ready-to-use solution.

Citrate buffer

For Antigen retrieval, prepare a 60x concentrated stock solution of citrate buffer with 9.15 g of citric acid (MW: 210.1), 70.35 g tri-sodium dihydrate (MW: 294.1) and 2.4 g Trisma Base (MW: 121.14) in 1L. Adjust pH to 5.7. storage at 4°C.

For ready-to-use solution, add 25ml of citrate buffer stock solution in 1475 ml milli Q water. Add 675 μl of 20X triton X-100 (4 ml of Triton 100 in 16 ml Milli Q water) for each 250 ml 1X citrate buffer. Storage at

PBS-Tween20

Prepare 0.1% (vol/vol) Tween 20 in PBS by adding 50 μl of Tween-20 in 50 ml PBS.

PBS-BSA 1%

Add 0.5g of BSA in 50 ml PBS.

Blocking and washing buffer

Prepare Organoid Washing Buffer with PBS containing 0.2% BSA and 0.1% Triton X-100 by adding 100 mg BSA and 50 μl Triton X-100 in 50 ml PBS.

Equipments

Consumables

  • 96 well plates, Greiner (G) Bio-one, CELLSTAR ® cat N° 655180

  • 24 well plates, Greiner (G) Bio-one, CELLSTAR ® cat N° 62210

  • 15 ml conic tubes, Greiner (G) Bio-one, CELLSTAR ® 88271N

Bench apparatus

  • Microwave oven

  • Incubator

  • Centrifuge

Microscopes

The images were acquired by a Zeiss LSM800 inverted confocal microscope equipped with 4 lasers (405, 488, 561 and 640 nm), Variable Secondary Dichroics, GaAsp detectors and x10/NA 0.3 Plan-Apochromat lens.

Software

Zen 3.5 (blue edition) and Imaris (Bitplane) were used for 3D reconstitution of the images acquired by a confocal microscope.

Supporting information

S1 Fig. Confocal images of Muc2 staining showing the different acquisition layers (z-stacks).

(TIF)

S2 Fig. Confocal images of OLFM4 staining showing the different acquisition layers (z-stacks).

(TIF)

pone.0315922.s002.tif (574.8KB, tif)
S3 Fig. Confocal images of Muc2 staining.

(TIF)

pone.0315922.s003.tif (264.7KB, tif)
S1 File. Step-by-step protocol, also available on protocols.io.

(PDF)

pone.0315922.s004.pdf (4.1MB, pdf)

Data Availability

All data files are available from the Protocol.io database (DOI: 10.17504/protocols.io.kqdg323m7v25/v1).

Funding Statement

The author(s) received no specific funding for this work.

References

  • 1.Clevers H. Modeling Development and Disease with Organoids. Cell. 2016. Jun 16;165(7):1586–1597. doi: 10.1016/j.cell.2016.05.082 . [DOI] [PubMed] [Google Scholar]
  • 2.Mahe MM, Aihara E, Schumacher MA, Zavros Y, Montrose MH, Helmrath MA, et al. Establishment of Gastrointestinal Epithelial Organoids. Curr Protoc Mouse Biol. 2013. Dec 19;3(4):217–40. doi: 10.1002/9780470942390.mo130179 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Wan Y, McDole K, Keller PJ. Light-Sheet Microscopy and Its Potential for Understanding Developmental Processes. Annu Rev Cell Dev Biol. 2019. Oct 6;35:655–681. doi: 10.1146/annurev-cellbio-100818-125311 [DOI] [PubMed] [Google Scholar]
  • 4.de Medeiros G, Ortiz R, Strnad P, Boni A, Moos F, Repina N, et al. Multiscale light-sheet organoid imaging framework. Nat Commun. 2022. Aug 18;13(1):4864. doi: 10.1038/s41467-022-32465-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Dekkers JF, Alieva M, Wellens LM, Ariese HCR, Jamieson PR, Vonk AM, et al. High-resolution 3D imaging of fixed and cleared organoids. Nat Protoc. 2019. Jun;14(6):1756–1771. doi: 10.1038/s41596-019-0160-8 [DOI] [PubMed] [Google Scholar]
  • 6.Hoffman EA, Frey BL, Smith LM, Auble DT. Formaldehyde crosslinking: a tool for the study of chromatin complexes. J Biol Chem. 2015. Oct 30;290(44):26404–11. doi: 10.1074/jbc.R115.651679 Epub 2015 Sep 9. ; PMCID: PMC4646298. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Dunkenberger L, Del Valle L. Antigen Retrieval and Signal Amplification. Methods Mol Biol. 2022;2422:65–74. doi: 10.1007/978-1-0716-1948-3_5 [DOI] [PubMed] [Google Scholar]
  • 8.Messal HA, Almagro J, Zaw Thin M, Tedeschi A, Ciccarelli A, Blackie L, et al. Antigen retrieval and clearing for whole-organ immunofluorescence by FLASH. Nat Protoc. 2021. Jan;16(1):239–262. doi: 10.1038/s41596-020-00414-z [DOI] [PubMed] [Google Scholar]
  • 9.Charlet-Faure C, Thulesen AP, Rogowska-Wrzesinska A. Advancements in 3D spheroid imaging: Optimised cryosectioning and immunostaining techniques. MethodsX. 2023. Oct 6;11:102415. doi: 10.1016/j.mex.2023.102415 ; PMCID: PMC10582779. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Krenacs L, Krenacs T, Stelkovics E, Raffeld M. Heat-induced antigen retrieval for immunohistochemical reactions in routinely processed paraffin sections. Methods Mol Biol. 2010;588:103–19. doi: 10.1007/978-1-59745-324-0_14 ; PMCID: PMC7604828. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Patiño-García D., Rocha-Pérez N., Moreno R. D., & Orellana R. (2019). Antigen retrieval by citrate solution improves western blot signal. MethodsX, 6, 464–468. doi: 10.1016/j.mex.2019.02.030 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Shi S. R., Shi Y., & Taylor C. R. (2011). Antigen retrieval immunohistochemistry: Review and future prospects in research and diagnosis over two decades. Journal of Histochemistry and Cytochemistry, 59(1), 13–32. doi: 10.1369/jhc.2010.957191 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Ayman A Swelum

17 Oct 2024

PONE-D-24-359333D fluorescence staining and imaging of low amount of organoids: protocol accessible to allPLOS ONE

Dear Dr. TOULEHOHOUN,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

==============================

ACADEMIC EDITOR: Please follow all reviewers comments and reply for their questions. 

==============================

Please submit your revised manuscript by Dec 01 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Ayman A. Swelum

Academic Editor

PLOS ONE

Journal requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. When completing the data availability statement of the submission form, you indicated that you will make your data available on acceptance. We strongly recommend all authors decide on a data sharing plan before acceptance, as the process can be lengthy and hold up publication timelines. Please note that, though access restrictions are acceptable now, your entire data will need to be made freely accessible if your manuscript is accepted for publication. This policy applies to all data except where public deposition would breach compliance with the protocol approved by your research ethics board. If you are unable to adhere to our open data policy, please kindly revise your statement to explain your reasoning and we will seek the editor's input on an exemption. Please be assured that, once you have provided your new statement, the assessment of your exemption will not hold up the peer review process.

3. We note that you have included the phrase “data not shown” in your manuscript. Unfortunately, this does not meet our data sharing requirements. PLOS does not permit references to inaccessible data. We require that authors provide all relevant data within the paper, Supporting Information files, or in an acceptable, public repository. Please add a citation to support this phrase or upload the data that corresponds with these findings to a stable repository (such as Figshare or Dryad) and provide and URLs, DOIs, or accession numbers that may be used to access these data. Or, if the data are not a core part of the research being presented in your study, we ask that you remove the phrase that refers to these data.

4. We note you have not yet provided a protocols.io PDF version of your protocol and/or a protocols.io DOI. When you submit your revision, please provide a PDF version of your protocol as generated by protocols.io (the file will have the protocols.io logo in the upper right corner of the first page) as a Supporting Information file. The filename should be S1_file.pdf, and you should enter “S1 File” into the Description field. Any additional protocols should be numbered S2, S3, and so on. Please also follow the instructions for Supporting Information captions [https://journals.plos.org/plosone/s/supporting-information#loc-captions]. The title in the caption should read: “Step-by-step protocol, also available on protocols.io.”

Please assign your protocol a protocols.io DOI, if you have not already done so, and include the following line in the Materials and Methods section of your manuscript: “The protocol described in this peer-reviewed article is published on protocols.io (https://dx.doi.org/10.17504/protocols.io.[...]) and is included for printing purposes as S1 File.” You should also supply the DOI in the Protocols.io DOI field of the submission form when you submit your revision.

If you have not yet uploaded your protocol to protocols.io, you are invited to use the platform’s protocol entry service [https://www.protocols.io/we-enter-protocols] for doing so, at no charge. Through this service, the team at protocols.io will enter your protocol for you and format it in a way that takes advantage of the platform’s features. When submitting your protocol to the protocol entry service please include the customer code PLOS2022 in the Note field and indicate that your protocol is associated with a PLOS ONE Lab Protocol Submission. You should also include the title and manuscript number of your PLOS ONE submission.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Does the manuscript report a protocol which is of utility to the research community and adds value to the published literature?

Reviewer #1: No

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: Yes

Reviewer #5: No

Reviewer #6: No

Reviewer #7: Yes

**********

2. Has the protocol been described in sufficient detail?

To answer this question, please click the link to protocols.io in the Materials and Methods section of the manuscript (if a link has been provided) or consult the step-by-step protocol in the Supporting Information files.

The step-by-step protocol should contain sufficient detail for another researcher to be able to reproduce all experiments and analyses.

Reviewer #1: No

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: Yes

Reviewer #5: Yes

Reviewer #6: Yes

Reviewer #7: Yes

**********

3. Does the protocol describe a validated method?

The manuscript must demonstrate that the protocol achieves its intended purpose: either by containing appropriate validation data, or referencing at least one original research article in which the protocol was used to generate data.

Reviewer #1: No

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: Yes

Reviewer #5: Yes

Reviewer #6: Yes

Reviewer #7: No

**********

4. If the manuscript contains new data, have the authors made this data fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: Yes

Reviewer #3: No

Reviewer #4: Yes

Reviewer #5: No

Reviewer #6: N/A

Reviewer #7: N/A

**********

5. Is the article presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please highlight any specific errors that need correcting in the box below.

Reviewer #1: No: must need proof reading services

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: Yes

Reviewer #5: Yes

Reviewer #6: No: There are spelling mistakes and English grammar errors. Editing is recommended.

Reviewer #7: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The manuscript was poorly written, and the authors failed to convince that the method they developed was reliable and repeatable based on what was presented here. The heat-induced method of epitope retrieval was a well-established technique routinely used for histological staining. The sandwich method of placing organoids and paraformaldehyde fixation is recommended by Corning and routinely used in organoid labs. Hence, I do not see novelty in their study. In the abstract, the authors mentioned that 3D imaging is necessary but failed to show 3D imaging techniques such as Light-sheet microscopy. I think the authors should have at least shown a confocal-built 3D image. It is well known, and even described in the Matrigel manual, that the proteins in Matrigel can autofluoresce. Lastly, when the authors claim that they developed an easy workflow for staining, they should have compared their method with a more difficult workflow and summarized their results in a table/figures.

Comments:

1. Line 28: “mimicking patient…”, why not animals? Organoids were generated in animals; re-phrase this statement.

2. Figure 3: I can't find all the images described in the figure legend

3. Table 1 should include conc. , not dilutions of antibodies.

4. Must add more references for some of the statements quoted, e.g. lines 54-55

5. Line 139: what is 1/200?

6. Line 143: what is a chelation buffer? I think there may be additional components in this buffer.

7. Line 146: “…min)?

8. Line 200: Which culture medium?

9. Line 214: Once Matrigel is polymerized, how can the organoids attach?

10. Line 270: Compared to which techniques??

11. It looks like a copy-paste lab protocol, not proofread

12. Inconsistency in describing the vendors or manufacturer throughout the manuscript. Corning is the manufacturer, not VWR

13. It is interesting to see only one manuscript referenced from Dr. Clever's lab

14. This manuscript requires thorough proofreading for grammar, spell-checks, font sizes, and inconsistency.

Reviewer #2: This protocol described how to stain and image 3D organoids. Some questions are:

1. Please state the confocal microscope in the title, since 3D imaging could be archieved by other ways, for example fluorescent MOST.

2. In looking at the presented images (2-4), it seems that they are not like 3D imaging, because they do not show the whole organoids. Did the authors only image a few layers, not the whole organoids?

3. How low is low amount?

4. Please state the types of organoids. Since they are from crypts, they should be intestine organoids. Then could this protocol be used to other organoids, such as brain organoids, since brain organoids contain more contact core.

Reviewer #3: The protocol is easy to comprehend and follow, but requires some fine tuning to be more applicable for efficient visualization at a higher magnification.

These are some minor comments:

There are some incomplete sentences in the methods (L141 and L146). Please revise and double-check.

For each image and in the protocol, please specify on which day of culture you sampled the organoids (day 7 till day 14).

Throughout the figures, there are inappropriate staining for DAPI. The nuclear boundaries are not clear. Do you have any explanation for this?

Also, for MUC2, it is restricted to particular pole of the organoids, why it is not homogenous throughout the lumen?

The same for LYZ, it appeared as you reduced the brightness and the images will be different when increasing the brightness.

Reviewer #4: The protocol presents an interesting and accessible option for researchers. While the manuscript offers valuable insights, including comparisons with the FLASH method, a more comprehensive evaluation is needed for a deeper understanding of its effectiveness. Comparing it with traditional techniques will further clarify its practical applications.

To strengthen the manuscript, I recommend adding comparisons between this protocol and results from traditional, slower methods, alongside FLASH. This will help: provide essential context on the efficacy and reliability of your approach; highlight potential advantages and limitations, particularly regarding resolution and structural preservation. Visual comparisons across different methods will enhance understanding, and incorporating established protocols will better situate your findings within existing literature, bolstering the study’s credibility. Furthermore, it would be beneficial to explore whether this method is applicable to organoids other than those derived from the duodenal mucosa.

Reviewer #5: Dear author the protocol presented add the microwave to demask antigens that could be a TIP to improve the antigen-antibody recognizon for this reason the protocol is not particular original

could the authors add additional use of this protocol not only for imaging

however some steps need to be clarify such as The step with citrate buffer at RT . Is the working solution at this step 10X?

Does Organoid Washing Buffer contain 1ml of Triton 100% with 2g BSA? please indicate in the step

Lysozymes and MUC2 are not present images these markers are important because are intracellular to show if the antibody is able to go inside the cell

Reviewer #6: Re: 3D Fluorescence Staining and Imaging of Low Amount of Organoids: Protocol Accessible to All

Organoids are miniature tissues that exhibit the structure and specific functions of various organs. In recent years, with the advancement of organoid production techniques, these models have significantly contributed to the study and understanding of the mechanisms involved in the pathogenesis of various diseases. The ability to visualize organoids using three-dimensional fluorescence techniques in many cases, and the preparation of these organoids for imaging, are of crucial importance. The researchers who developed this protocol noted that in a microwave-based antigen retrieval method, which they term HIER, the target antigenic epitopes are unmasked, facilitating easier and more efficient labeling of the cells that compose the organoids. However, it is important to note that the microwave antigen retrieval method is not a novel technique, and it has not yielded consistent results across all antibodies they aimed to demonstrate. Additionally, I have further critiques and suggestions as outlined below.

Main Comments:

The background/introduction section of the protocol paper lacks sufficient citations. Certain statements sharing information and research results are not attributed to any specific study, despite not being original findings of this work.

In your results, you stated that no data were shown for MUC2, LYZ, and OLFM4 due to non-specific staining in intestinal organoids. However, OLFM4 staining is visible in Fig. 3. Furthermore, the figure legend of Fig. 3 indicates that OLFM4 is labeled in red in panels A and B, MUC2 is labeled in green in panels C and D, and LYZ is labeled in red in panels E and F. However, the figure file only contains panels A and B, where OLFM4 staining is visible. This discrepancy needs to be addressed and clarified.

Why did you perform imaging on a confocal microscope after tissue clearing? The resolution still appears to be low. Using light-sheet microscopy instead could improve image quality and better highlight the key steps in your protocol.

It is recommended to share the key parameters (e.g., exposure time, gain, etc.) used in the confocal imaging process.

Additionally, when referring to intestinal organoids, it is suggested to indicate "enteroids" in parentheses upon the first mention and to consistently use "enteroids" in subsequent sections.

Reviewer #7: The protocol is generally clear and well-written. The only major request I have is to indicate how many organoids have been successfully stained with this protocol.

Has this protocol been used in a published work?

Plaese note that on line 146 timing is missing.

Please carefully check English spelling, e.g. line 17: “lost” should be replaced with “loss”, line 57:”brake” should be replaced with “break”

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: Yes: Islam M. Saadeldin

Reviewer #4: No

Reviewer #5: No

Reviewer #6: Yes: Dr. Özgecan Kayalar (MSc., PhD.)

Reviewer #7: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: Minor revisions.pdf

pone.0315922.s005.pdf (77.3KB, pdf)
PLoS One. 2025 Jan 15;20(1):e0315922. doi: 10.1371/journal.pone.0315922.r002

Author response to Decision Letter 0


30 Nov 2024

Dear reviewers,

We thank you for your insightful comments on the protocol. This has added a great value to the content of the manuscript. The revisions were made according to your remarks.

We look forward to hearing from you.

Best regards,

Ami Gloria Toulehohoun

Attachment

Submitted filename: Response to reviewers.docx

Decision Letter 1

Ayman A Swelum

4 Dec 2024

3D fluorescence staining and confocal imaging of low amount of intestinal organoids (enteroids): protocol accessible to all

PONE-D-24-35933R1

Dear Dr. Ami Gloria TOULEHOHOUN,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Ayman A. Swelum

Academic Editor

PLOS ONE

Acceptance letter

Ayman A Swelum

23 Dec 2024

PONE-D-24-35933R1

PLOS ONE

Dear Dr. TOULEHOHOUN,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Professor Ayman A. Swelum

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Fig. Confocal images of Muc2 staining showing the different acquisition layers (z-stacks).

    (TIF)

    S2 Fig. Confocal images of OLFM4 staining showing the different acquisition layers (z-stacks).

    (TIF)

    pone.0315922.s002.tif (574.8KB, tif)
    S3 Fig. Confocal images of Muc2 staining.

    (TIF)

    pone.0315922.s003.tif (264.7KB, tif)
    S1 File. Step-by-step protocol, also available on protocols.io.

    (PDF)

    pone.0315922.s004.pdf (4.1MB, pdf)
    Attachment

    Submitted filename: Minor revisions.pdf

    pone.0315922.s005.pdf (77.3KB, pdf)
    Attachment

    Submitted filename: Response to reviewers.docx

    Data Availability Statement

    All data files are available from the Protocol.io database (DOI: 10.17504/protocols.io.kqdg323m7v25/v1).


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES